GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $857,950 | -42.7% | 226,372 | -16.9% | 0.00% | -100.0% |
| Q2 2023 | $1,497,783 | +123991.4% | 272,324 | -3.0% | 0.00% | – |
| Q1 2023 | $1,207 | -10.2% | 280,622 | -18.0% | 0.00% | -100.0% |
| Q4 2022 | $1,344 | -99.9% | 342,061 | -4.6% | 0.00% | 0.0% |
| Q3 2022 | $1,905,000 | -7.2% | 358,648 | +14.6% | 0.00% | 0.0% |
| Q2 2022 | $2,052,000 | -14.7% | 312,877 | +80.8% | 0.00% | 0.0% |
| Q1 2022 | $2,405,000 | +29.0% | 173,028 | +29.0% | 0.00% | 0.0% |
| Q4 2021 | $1,864,000 | -48.8% | 134,112 | -7.4% | 0.00% | 0.0% |
| Q3 2021 | $3,641,000 | -15.3% | 144,861 | -9.4% | 0.00% | 0.0% |
| Q2 2021 | $4,299,000 | +27.9% | 159,819 | +35.3% | 0.00% | 0.0% |
| Q1 2021 | $3,362,000 | +154.3% | 118,120 | +153.4% | 0.00% | – |
| Q4 2020 | $1,322,000 | -7.1% | 46,608 | +1.3% | 0.00% | -100.0% |
| Q3 2020 | $1,423,000 | – | 46,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |